Health and Fitness Health and Fitness
Fri, December 19, 2008
[ Fri, Dec 19th 2008 ] - Market Wire
Medtronic Acquires Remaining Shares of CryoCath Technologies Inc.
[ Fri, Dec 19th 2008 ] - Market Wire
Alnylam Publishes Pre-Clinical Research on Direct CNS Delivery of RNAi Therapeutics
[ Fri, Dec 19th 2008 ] - Market Wire
Protalix BioTherapeutics Announces First Patient .. hover Trial of prGCD for the Treatment of Gaucher
[ Fri, Dec 19th 2008 ] - Market Wire
Emergent BioSolutions Receives FDA Approval for B .. oThrax Supplemental Biologics License Application
[ Fri, Dec 19th 2008 ] - Market Wire
Dynavax Announces Termination of Partnership With Merck for HEPLISAV" Hepatitis B Vaccine
[ Fri, Dec 19th 2008 ] - Market Wire
Centene Corporation Announces 2009 Financial Guidance and Related Updates
[ Fri, Dec 19th 2008 ] - Market Wire
ArthroCare Announces Expansion of Periods Covered .. Statements and Withdrawal of Previously Disclosed
[ Fri, Dec 19th 2008 ] - Market Wire
Zacks Analyst Interview Highlights: Wellpoint, Humana and Healthsouth
Thu, December 18, 2008
[ Thu, Dec 18th 2008 ] - Market Wire
Skyepharma PLC: Skyepharma - Update on Formoterol Certihaler
[ Thu, Dec 18th 2008 ] - Market Wire
Phase III Study Showed Rituxan Decreased the Prog .. in Patients with Early Rheumatoid Arthritis (RA)
[ Thu, Dec 18th 2008 ] - Market Wire
PPD erweitert seine Ttigkeiten auf dem Gebiet der Auftragsforschung nach Irland
[ Thu, Dec 18th 2008 ] - Market Wire
PPD estender le attivit di ricerca a contratto allIrlanda
[ Thu, Dec 18th 2008 ] - Market Wire
KCI Files Patent Infringement Suit Against Convatec and Boehringer
[ Thu, Dec 18th 2008 ] - Market Wire
Meridian Co., Ltd.: Meridian Medical Inc. (Exclus .. r for Meridian Co.) Signs a Key Distribution Agre
[ Thu, Dec 18th 2008 ] - Market Wire
TomoTherapy Announces Workforce Reduction
[ Thu, Dec 18th 2008 ] - Market Wire
Baxter Receives EMEA Positive Opinion for CELVAPA .. The First Cell Culture-Based Pandemic Flu Vaccine
[ Thu, Dec 18th 2008 ] - Market Wire
King Pharmaceuticals Announces Submission of New Drug Application for CorVue"
[ Thu, Dec 18th 2008 ] - Market Wire
PDL BioPharma: PDL BioPharma Appoints Christine Larson as VP and CFO
[ Thu, Dec 18th 2008 ] - Market Wire
Spectranetics International, B.V. Achieves New Sales Milestone
[ Thu, Dec 18th 2008 ] - Market Wire
Exelixis Announces January 13 Webcast of Presenta .. at the 27th Annual JPMorgan Healthcare Conference
[ Thu, Dec 18th 2008 ] - Market Wire
NitroMed Confirms Receipt of Letter from Deerfield Management
[ Thu, Dec 18th 2008 ] - Market Wire
Targanta Announces Corporate Restructuring
[ Thu, Dec 18th 2008 ] - Market Wire
Toxin Alert Inc.: Toxin Alert Inc. Closes First Tranche of Private Placement
[ Thu, Dec 18th 2008 ] - Market Wire
Bennett Environmental Inc.: BEI Sentence Confirmed in Department of Justice Proceeding
[ Thu, Dec 18th 2008 ] - Market Wire
American Shared Hospital Services Announces Contr .. Knife Perfexion System to Kettering Medical Cent
[ Thu, Dec 18th 2008 ] - Market Wire
Big Stick Media Corporation: Big Stick Media Corporation Announces Resignation of a Director
[ Thu, Dec 18th 2008 ] - Market Wire
Proteonomix, Inc.: Proteonomix, Inc. Announces th .. Use of Umbilical Cord Blood in Growing Undifferen
[ Thu, Dec 18th 2008 ] - Market Wire
Healthways to Report Earnings for Three Months En .. t Conference Call after Market Close on January 8
[ Thu, Dec 18th 2008 ] - Market Wire
Alturas Minerals Corp.: Alturas Defines Large Geo .. pper-Gold Anomalies at Its Sombrero Project, Peru
[ Thu, Dec 18th 2008 ] - Market Wire
CardioDynamics International: California Equity R .. overage of CardioDynamics Intl. With a Buy Rating

CardioDynamics International: California Equity Research Initiates Coverage of CardioDynamics Intl. With a Buy Rating


Published on 2008-12-18 08:04:18 - Market Wire
  Print publication without navigation


SAN DIEGO, CA--(Marketwire - December 18, 2008) - California Equity Research, LLC, a leading independent investment research firm focused on California equities, is initiating coverage of CardioDynamics International Corporation (NASDAQ: [ CDIC ]) ($0.60) with a Buy rating and price target of $3.50. The following excerpts are from the CardioDynamics research report. 

 -- CardioDynamics shares are significantly undervalued trading at a TTM revenue multiple of 0.17x. -- CardioDynamics revenue is expected to grow at an 8% annual rate through 2010 based on: -- New initiatives and additions to sales and marketing -- Next generation BioZ product to be released in late 2009 -- Growing traction in overseas markets particularly Eastern Europe -- Important clinical studies due for release in 2010 on hypertension and CHF

More information on the 21-page CardioDynamics research report can be obtained by calling 866.928.2600 or by visiting online at [ www.CalEquityResearch.com ]. Please refer to our website for a full list of disclosures.

California Equity Research, LLC is an independent, research-only investment firm that exclusively covers underfollowed opportunities in California. Our research is produced by experienced analysts that have one committed goal: providing timely, value-added research ideas to our clients. For more information about California Equity Research please visit us online at [ www.CalEquityResearch.com ] or call 866.928.2600.

Contributing Sources